Market Closed -
Bombay S.E.
06:00:47 2024-05-15 EDT
|
5-day change
|
1st Jan Change
|
195.8
INR
|
+0.26%
|
|
-2.59%
|
+17.07%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,180
|
1,829
|
1,100
|
4,204
|
6,011
|
3,848
|
Enterprise Value (EV)
1 |
3,674
|
2,513
|
1,658
|
4,480
|
6,699
|
4,638
|
P/E ratio
|
21.6
x
|
11.1
x
|
4.47
x
|
12.9
x
|
25.2
x
|
16.8
x
|
Yield
|
0.52%
|
0.9%
|
1.5%
|
0.52%
|
0.37%
|
0.57%
|
Capitalization / Revenue
|
0.95
x
|
0.4
x
|
0.27
x
|
0.94
x
|
1.06
x
|
0.64
x
|
EV / Revenue
|
1.1
x
|
0.55
x
|
0.41
x
|
1
x
|
1.18
x
|
0.78
x
|
EV / EBITDA
|
12.9
x
|
7.4
x
|
3.68
x
|
7.79
x
|
15
x
|
10.9
x
|
EV / FCF
|
37.6
x
|
-36.2
x
|
-17
x
|
20.7
x
|
-15.1
x
|
-37.3
x
|
FCF Yield
|
2.66%
|
-2.76%
|
-5.87%
|
4.83%
|
-6.63%
|
-2.68%
|
Price to Book
|
4.67
x
|
2.23
x
|
1.02
x
|
2.99
x
|
3.7
x
|
2.11
x
|
Nbr of stocks (in thousands)
|
55,020
|
55,020
|
55,020
|
55,020
|
55,020
|
55,020
|
Reference price
2 |
57.80
|
33.25
|
20.00
|
76.40
|
109.2
|
69.94
|
Announcement Date
|
18-09-03
|
19-09-01
|
20-09-05
|
21-08-30
|
22-09-03
|
23-09-06
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,332
|
4,551
|
4,025
|
4,466
|
5,678
|
5,973
|
EBITDA
1 |
284.9
|
339.7
|
449.9
|
575.2
|
447.4
|
424.8
|
EBIT
1 |
259.7
|
312.8
|
420.2
|
534.1
|
403.8
|
376.7
|
Operating Margin
|
7.79%
|
6.87%
|
10.44%
|
11.96%
|
7.11%
|
6.31%
|
Earnings before Tax (EBT)
1 |
229.8
|
257.8
|
303.8
|
439.4
|
321.7
|
302.9
|
Net income
1 |
147.6
|
164.3
|
246
|
325.9
|
238.6
|
228.7
|
Net margin
|
4.43%
|
3.61%
|
6.11%
|
7.3%
|
4.2%
|
3.83%
|
EPS
2 |
2.680
|
2.986
|
4.470
|
5.920
|
4.336
|
4.157
|
Free Cash Flow
1 |
97.66
|
-69.43
|
-97.27
|
216.2
|
-444.2
|
-124.5
|
FCF margin
|
2.93%
|
-1.53%
|
-2.42%
|
4.84%
|
-7.82%
|
-2.08%
|
FCF Conversion (EBITDA)
|
34.27%
|
-
|
-
|
37.59%
|
-
|
-
|
FCF Conversion (Net income)
|
66.18%
|
-
|
-
|
66.35%
|
-
|
-
|
Dividend per Share
2 |
0.3000
|
0.3000
|
0.3000
|
0.4000
|
0.4000
|
0.4000
|
Announcement Date
|
18-09-03
|
19-09-01
|
20-09-05
|
21-08-30
|
22-09-03
|
23-09-06
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
494
|
683
|
557
|
277
|
688
|
789
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.734
x
|
2.011
x
|
1.238
x
|
0.4811
x
|
1.537
x
|
1.858
x
|
Free Cash Flow
1 |
97.7
|
-69.4
|
-97.3
|
216
|
-444
|
-124
|
ROE (net income / shareholders' equity)
|
23.8%
|
21.8%
|
25.8%
|
26.2%
|
15.7%
|
13.3%
|
ROA (Net income/ Total Assets)
|
9.24%
|
8.84%
|
10.9%
|
12.4%
|
8.2%
|
7.2%
|
Assets
1 |
1,598
|
1,858
|
2,265
|
2,620
|
2,908
|
3,176
|
Book Value Per Share
2 |
12.40
|
14.90
|
19.60
|
25.60
|
29.50
|
33.20
|
Cash Flow per Share
2 |
0.8800
|
1.890
|
0.4100
|
8.350
|
0.6000
|
1.060
|
Capex
1 |
79.2
|
84.6
|
268
|
109
|
83.4
|
21.9
|
Capex / Sales
|
2.38%
|
1.86%
|
6.67%
|
2.44%
|
1.47%
|
0.37%
|
Announcement Date
|
18-09-03
|
19-09-01
|
20-09-05
|
21-08-30
|
22-09-03
|
23-09-06
|
|
1st Jan change
|
Capi.
|
---|
| +17.07% | 129M | | -0.96% | 74.01B | | +1.76% | 47.66B | | +1.90% | 32.76B | | +10.03% | 18.17B | | +11.99% | 11.85B | | -14.66% | 11.16B | | +2.04% | 10.89B | | +0.72% | 9.49B | | -2.13% | 8.35B |
Diversified Chemicals
|